A Phase III Randomized Trial Investigating Bortezomib (NSC#681239; IND#58443) on a Modified Augmented BFM (ABFM) Backbone in Newly Diagnosed T- Lymphoblastic Leukemia (T-ALL) aAd T­ Lymphoblastic Lymphoma (T-LLy)

General Information

Age Group

Pediatrics/Children

Status

Active

Protocol Number

AALL1231

Offered At

Inova Children's Hospital
3300 Gallows Road
Falls Church, VA 22042